-
Home |
Professional Development
From The Latest Issue
-
Case Studies
Case Study |
Dr Eugene Moylan, Consultant Medical Oncologist, Cork University Hospital And Kerry General Hospital
|
23 Feb 2012
Results of a recent clinical trial suggest that everolimus has the potential to be a new targeted treatment for the problem of resistance to endocrine therapies in hormone-receptor positive breast cancer
-
Research
SABCS |
23 Feb 2012
Data evaluated by an independent review committee revealed that the addition of bevacizumab to trastuzumab and docetaxel significantly improved progression-free survival in HER2-positive breast cancer, despite findings from an investigator assessment that the improvement was present, but statistically non-significant.
-
Research
SABCS |
23 Feb 2012
Results from a German study demonstrated no improvement in disease-free survival among patients with breast cancer who were treated with dose-dense chemotherapy and the bisphosphonate ibandronate.
-
Research
Research |
23 Feb 2012
According to recent US research, the use of metformin among women with type 2 diabetes and ovarian cancer may be associated with better progression-free survival time compared with non-use
-
Research
Research |
23 Feb 2012
MRI is more sensitive than mammography in high-risk women, but there is no proof of reduced mortality
-
Management
David McConaghy, GP, Sallins Medical Centre, Sallins, Kildare
|
23 Feb 2012
While clinical audit is now a requirement under CPD, it is not something to be feared as it can have a positive influence on patient outcomes, productivity and the bottom line
-
MCQS
23 Feb 2012
Test your knowledge with this mini-quiz for the busy doctor. Please note answers at the end
-
Research
SABCS |
23 Feb 2012
A Phase 3 study with pertuzumab in HER2-positive metastatic breast cancer found a 6.1 month improvement in median progression free survival from 12.4 to 18.5 months.
-
Research
SABCS |
23 Feb 2012
Breast cancer survivors who carry the BRCA1 or BRCA2 genetic mutation are at high risk for developing contralateral breast cancer and certain women within this group of carriers are at an even greater risk based on age at diagnosis and first tumour status, according to data presented at the San Antonio Symposium.
From previous issues
-
Research
Judith Leavy
|
09 Feb 2012
Results from a recent study at Gothenburg University suggest that the contraceptive pill reduces the severity of dysmenorrhoea, writes Judith Leavy
-
Case Studies
Case Study |
Dr Cathy Burke, Consultant In Obstetrics And Gynaecology, Cork University Hospital, Wilton, Cork
|
09 Feb 2012
Endometriosis can have a negative impact on quality of life. Depending on severity, there are a number of medical and surgical management options to be considered
-
MCQS
09 Feb 2012
Test your knowledge with this mini-quiz for the busy doctor. Please note answers at the end
-
Management
09 Feb 2012
A recent meeting of the European Society of Human Reproduction and Embryology and the American Society for Reproductive Medicine set out to standardise guidelines and identify future research needs
-
Research
Judith Leavy
|
26 Jan 2012
An overview in prevention and management strategies
-
Case Studies
Case Study |
Dr Ciara McDonnell, Consultant Paediatrician in Endocrinology and Diabetes, Children's University Hospital, Temple Street and Our Lady's Children's Hospital, Crumlin
|
26 Jan 2012
Careful examination is required before making a diagnosis of osteoporosis in adolescents and children
-
MCQS
26 Jan 2012
Test your knowledge with this mini-quiz for the busy doctor. Please note answers at the end
-
Case Studies
Case Study |
Dr Poochellan Muthalagu, Consultant Endocrine Physician, Cavan/Monaghan Hospital Group, Cavan.
|
26 Jan 2012
Dr Poochellum Muthalagu runs through osteoporosis diagnosis and treatment in primary care in this two case question and answer review
-
Case Studies
Case Study |
Dr Montasser Nadeem And Prof Enda Roche, Department Of Paediatrics, Trinity College Dublin, Amnch, Tallaght, Dublin 24
|
12 Jan 2012
This chromosomal abnormality requires a multidisciplinary approach which changes throughout the life cycle of the patient
-
Feature
Feature |
12 Jan 2012
Dr Phil Raskin, Professor of Medicine at the University of Texas Southwestern Medical Center at Dallas in Texas, and Dr Larry Blonde, Director of the Ochsner Diabetes Clinical Research Unit and the Department of Endocrinology, Diabetes, and Metabolic Diseases at the Ochsner Medical Center in New Orleans, Louisiana address the role of insulin therapy in patients with Type 2 diabetes and evaluate new clinical trial data on novel insulin and delivery devices that were presented during the 71st Annual Scientific Sessions of the American Diabetes Association (ADA) in June of this year. They also discuss investigational agents not yet approved by the US Food and Drug Administration (FDA). Judith Leavy reports
-
MCQS
12 Jan 2012
Test your knowledge with this mini-quiz for the busy doctor. Please note answers at the end